Literature DB >> 15831607

Heart failure post-myocardial infarction: a review of the issues.

H Dargie1.   

Abstract

In most patients with heart failure due to left ventricular systolic dysfunction, the underlying cause is coronary heart disease. To reduce progression to heart failure in a patient with acute myocardial infarction, it is important to achieve the earliest possible reperfusion, whether by thrombolysis or primary percutaneous coronary intervention. Every patient with acute myocardial infarction should have an assessment of their left ventricular function, the potential for reversibility should be considered, and reversible ischaemia should be identified. Left ventricular dysfunction does not only occur with ST segment elevation myocardial infarction but is also commonly associated with non-ST segment elevation myocardial infarction. Secondary prevention is crucial and this requires long term commitment by the patient and the health care system. Heart failure and left ventricular dysfunction are treatable but require a multidisciplinary, integrated network approach.

Entities:  

Mesh:

Year:  2005        PMID: 15831607      PMCID: PMC1876346          DOI: 10.1136/hrt.2005.062018

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  13 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis.

Authors:  J Rawles
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

3.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

4.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

Authors:  D A Morrow; C P Cannon; N Rifai; M J Frey; R Vicari; N Lakkis; D H Robertson; D A Hille; P T DeLucca; P M DiBattiste; L A Demopoulos; W S Weintraub; E Braunwald
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

5.  Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction.

Authors:  K MacIntyre; S Stewart; S Capewell; J W Chalmers; J P Pell; J Boyd; A Finlayson; A Redpath; H Gilmour; J J McMurray
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points.

Authors:  J G Cleland; J C Daubert; E Erdmann; N Freemantle; D Gras; L Kappenberger; W Klein; L Tavazzi
Journal:  Eur J Heart Fail       Date:  2001-08       Impact factor: 15.534

7.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors:  E Boersma; A C Maas; J W Deckers; M L Simoons
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

8.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

Authors:  Cecilia Linde; Christophe Leclercq; Steve Rex; Stephane Garrigue; Thomas Lavergne; Serge Cazeau; William McKenna; Melissa Fitzgerald; Jean-Claude Deharo; Christine Alonso; Stuart Walker; Frieder Braunschweig; Christophe Bailleul; Jean-Claude Daubert
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

View more
  19 in total

1.  Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database.

Authors:  Izyan A Wahab; Nicole L Pratt; Lisa Kalisch Ellett; Elizabeth E Roughead
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

2.  Making cardiomyocytes with your chemistry set: Small molecule-induced cardiogenesis in somatic cells.

Authors:  Woong-Hee Kim; Da-Woon Jung; Darren Reece Williams
Journal:  World J Cardiol       Date:  2015-03-26

3.  Enhancement of early cardiac differentiation of dedifferentiated fat cells by dimethyloxalylglycine via notch signaling pathway.

Authors:  Fuhai Li; Zongzhuang Li; Zhi Jiang; Ye Tian; Zhi Wang; Wei Yi; Chenyun Zhang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 4.  Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation.

Authors:  Zhiqiang Lin; William T Pu
Journal:  Stem Cell Res       Date:  2014-05-06       Impact factor: 2.020

5.  Therapeutic Delivery of Pip4k2c-Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart.

Authors:  Ajit Magadum; Neha Singh; Ann Anu Kurian; Mohammad Tofael Kabir Sharkar; Nishat Sultana; Elena Chepurko; Keerat Kaur; Magdalena M Żak; Yoav Hadas; Djamel Lebeche; Susmita Sahoo; Roger Hajjar; Lior Zangi
Journal:  Adv Sci (Weinh)       Date:  2021-03-12       Impact factor: 17.521

6.  In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy.

Authors:  Nishat Sultana; Mohammad Tofael Kabir Sharkar; Yoav Hadas; Elena Chepurko; Lior Zangi
Journal:  Methods Mol Biol       Date:  2021

7.  Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure.

Authors:  Agata Maciejak; Marek Kiliszek; Marcin Michalak; Dorota Tulacz; Grzegorz Opolski; Krzysztof Matlak; Slawomir Dobrzycki; Agnieszka Segiet; Monika Gora; Beata Burzynska
Journal:  Genome Med       Date:  2015-03-14       Impact factor: 11.117

8.  A method for inferring medical diagnoses from patient similarities.

Authors:  Assaf Gottlieb; Gideon Y Stein; Eytan Ruppin; Russ B Altman; Roded Sharan
Journal:  BMC Med       Date:  2013-09-02       Impact factor: 8.775

9.  Diagnostic Performance of Selected Baseline Electrocardiographic Parameters for Prediction of Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Michał Kasprzak; Tomasz Fabiszak; Marek Koziński; Jacek Kubica
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

10.  Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.

Authors:  Enrico Torre; Giorgio Lorenzo Colombo; Sergio Di Matteo; Chiara Martinotti; Maria Chiara Valentino; Alberto Rebora; Francesca Cecoli; Eleonora Monti; Marco Galimberti; Paolo Di Bartolo; Germano Gaggioli; Giacomo Matteo Bruno
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.